Enter your dose cohort data to visualize dose-exposure relationships, safety signals across dose levels, and identify the optimal Phase 2 dose range. Designed for first-in-human and dose-escalation programs.
📋
Quick-Start Scenarios
Oncology (mAb)
CNS (Small Molecule)
Rare Disease (Peptide)
Custom Data
💊
Dose Cohort Data
Cohort
Dose (mg)
N
Cmax (ng/mL)
AUC0-24
t1/2 (h)
AE Rate (%)
Gr 3+ AE (%)
Dose-Exposure Relationship (Cmax)
Dose-Exposure Relationship (AUC)
Safety Profile by Dose
Therapeutic Index
🔥
Safety Signal Heatmap
🎯
Phase 2 Recommended Dose Range
Disclaimer: This tool is for exploratory planning and educational purposes only. It does not replace formal pharmacometric modeling or regulatory-grade analyses. All outputs are simulated estimates based on user-provided summary data. Not intended for regulatory submission.